Determination of hepatitis B virus (HBV) DNA in serum by nucleic acid screening
Yi Jiang Feixue Zhao Yubin Xie Dong Guo Yonghe Yan Yizhou Zou a Institute of Blood Transfusion,Changsha Blood Center,Changsha,Hunan,Chinab Department of Immunology,School of Basic Medicine Science,Central South University,Changsha,Hunan,China
DOI: https://doi.org/10.1080/10739149.2024.2405496
2024-09-20
Instrumentation Science & Technology
Abstract:The determination of serum hepatitis B Virus (HBV) DNA is of paramount significance in the comprehensive management of HBV infection. It aids in diagnosis, disease staging, and treatment monitoring, ultimately improving patient outcomes and reducing the burden of HBV-related morbidity and mortality. In this work, serum HBV DNA detection was performed using a novel nucleic acid screening system. The sensitivity, selectivity, repeatability, cross reactivity, and HBV DNA stability were evaluated and compared with published data. The detection limit of 95% was 29.12 IU/mL and the 95% confidence interval was from 23.71 to 34.55 IU/mL. Blood samples that contain free hemoglobin (1 g/L, 2 g/L, 4 g/L) and triglycerides (3 mmol/L, 6 mmol/L and 9 mmol/L) were also analyzed. The results demonstrated that the system can also be used in the presence of free hemoglobin and triglycerides. The mean of the cycle threshold (Ct) in 5-day replicates was 35.71 ± 0.35 with a coefficient of variation (CV) of 0.97%. The results of negative samples in the anti-cross contamination experiment showed no response. The coincidence rate for 3001 samples over 20 days of real-time stability measurements and external quality assessment samples was 100%. The results demonstrate the effectiveness of the nucleic acid system for HBV-DNA, providing a theoretical basis for other small and medium-sized blood stations or hospitals to these devices.
chemistry, analytical,instruments & instrumentation